FMP
SeaStar Medical Holding Corporation
ICU
NASDAQ
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
1.29 USD
-0.015 (-1.17%)
ICU Financial Statements
Year
2024
2023
2022
2021
Current Assets
3.77M
2.31M
3.04M
601k
Cash & Short Term Investments
1.82M
176k
47k
510k
Cash And Cash Equivalents
1.82M
176k
47k
510k
Short Term Investments
0
0
0
0
Net Receivables
112k
0
12k
58k
Inventory
0
0
0
0
Other Current Assets
0
0
0
0
Non-Current Assets
892k
1.21M
1.73M
2k
Property, Plant & Equipment
0
0
0
0
Goodwill And Intangible Assets
0
0
0
0
Goodwill
0
0
0
0
Intangible Assets
0
0
0
0
Long Term Investments
0
0
1.73M
0
Tax Assets
0
0
0
0
Other Non-Current Assets
892k
1.21M
2k
2k
Other Assets
0
0
0
0
Total Assets
4.66M
3.51M
4.77M
603k
-
-
-
-
Current Liabilities
6.84M
13.05M
5.35M
3.12M
Accounts Payable
3.05M
4.37M
1.93M
85k
Short Term Debt
574k
4.74M
1.18M
2.38M
Tax Payables
0
0
0
0
Deferred Revenue
0
0
0
186k
Other Current Liabilities
33k
2.41M
12.53M
471k
Total Current Liabilities
6.84M
13.05M
5.35M
3.12M
Total Non-Current Liabilities
0
4.34M
7.65M
73.65M
Long-Term Debt
0
4.34M
7.65M
244k
Deferred Revenue
0
0
0
0
Deferred Taxes Liabilities
0
0
0
0
Other Non Current liabilities
0
0
0
73.4M
Total Liabilities
6.84M
17.38M
13M
76.77M
Other Liabilities
0
0
0
0
Stockholders Equity
-2.18M
-13.87M
-8.23M
-76.17M
Common Stock
2k
5k
1k
1k
Retained Earnings
-139.56M
-114.73M
-99.33M
-76.31M
Accumulated Other Comprehensive Income/Loss
0
0
-0
0
Other Shareholders Equity
137.38M
0
0
0
Total Liabilities and Stockholders Equity
4.66M
3.51M
4.77M
603k
Retained Earning Schedule
Year
2024
2023
2022
2021
Retained Earnings (Previous Year)
-114.73M
-99.33M
-76.31M
-71.72M
Net Income
-24.83M
-26.23M
-23.01M
-4.6M
Stock Repurchases
0
0
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-139.56M
-114.73M
-99.33M
-76.31M
Other Distributions
-24.83M
-15.41M
-23.01M
-4.6M
PPE Schedule
Year
2024
2023
2022
2021
Gross PPE
0
0
0
0
Annual Depreciation
0
14.01M
11.61M
4.45M
Capital Expenditure
0
0
0
0
Net PPE
0
-14.01M
-11.61M
-4.45M
Intangible and Goodwill Schedule
Year
2024
2023
2022
2021
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
